Do Antiparasitic Medicines Treat Viruses? What Research Shows

A mate of mine sent me a screenshot a while back. Somebody’s post, lots of capital letters, saying a worm tablet could knock out a virus. His message underneath was just “Is this real??”

I said I’d have a look. Then I lost about three evenings to it.

This is me reading the studies and trying to make sense of them, so please don’t use it to decide what to take.

Short answer first, I suppose

Mostly no. Not in the way the screenshot meant.

But the question isn’t daft, and that’s what kept me reading. Antiparasitic medicines and viral infections keep turning up in the same papers, and there are reasons for that. Some of the reasons are decent. Some are a stretch.

I’ll try to keep the two apart.

Parasites vs. viruses, quickly

A parasite is a living thing that lives on or inside you and takes what it needs. Worms. Single-celled organisms like Giardia, or the malaria parasite. Mites, lice. They have their own bodies, metabolism, and often nerves and muscles.

A virus is much smaller and much stranger. It’s a scrap of genetic code in a protein coat. It can’t do anything until it gets inside one of your cells and borrows the machinery.

People still argue about whether a virus even counts as alive.

The differences between parasites and viruses are way bigger than the word “bug” suggests. We lump everything under “infection,” but a tapeworm and a cold virus have about as much in common as a dog and a USB stick.

How antiparasitic drugs work (the bit that changed my mind)

How antiparasitic drugs work depends on which one you mean. Take ivermectin, since it’s the one in the headlines. In worms and mites, it locks onto particular channels in nerves and muscle cells, called glutamate-gated chloride channels if you want the proper name. The parasite gets paralyzed and dies.

Humans don’t have that same setup in the same places, and the drug mostly stays out of the brain. That’s a big part of why it’s considered safe at normal doses.

Now think about a virus. No nerves. No muscles. Nothing to paralyse.

That’s really what antiviral vs. antiparasitic drugs come down to. Targets. A drug needs something to hit.

Antiviral drugs work based on what viruses actually do. Oseltamivir (Tamiflu) blocks an enzyme flu viruses use to escape cells. Remdesivir interferes with copying viral RNA. Paxlovid blocks a protease the coronavirus needs to build its proteins. Aciclovir (acyclovir in the US) gets in the way of herpes viruses copying their DNA. All of them aim at viral replication, which is a completely different job from anything a worm does.

So why did anyone think it might work?

A dish, basically.

In 2020, a team at Monash University in Australia reported that ivermectin sharply cut the amount of virus in infected cells in a lab. Headlines followed, fast. Then the social media posts, and then my mate’s screenshot.

Antivirl activity in laboratory studies is real information, and it’s a sensible first step. It just isn’t proof of anything in a person. The catch, which got far less attention, was that the concentration used in the dish was much higher than what you’d reach in your blood from a normal dose. Researchers pointed that out fairly quickly.

There were also ideas about how it might work, like interfering with how viral proteins get into the cell nucleus, or changing the host cell response to infection. Interesting. But they were ideas, not results.

Repurposing is a good idea (when it works)

Drug repurposing studies, meaning testing old drugs for new jobs, aren’t crank science. It’s quicker and cheaper than starting from scratch, because the safety side is already known. Dexamethasone, a cheap steroid, turned out to reduce deaths in people with severe COVID who needed oxygen. That was repurposing at its best.

Plenty of antiparasitic medicines got the same treatment during the pandemic. Hydroxychloroquine, an antimalarial, was the other famous one. It looked promising in early lab work, but then large trials found no real benefit.

So lab promise and real-world results are two different things. I keep having to relearn that.

What happened to actual people

Clinical research on antiparasitic drugs and COVID got big and quite quick. Three trials are worth knowing about.

The TOGETHER trial in Brazil tested ivermectin in outpatients and didn’t find it reduced hospitalization or the need for prolonged emergency care. Then ACTIV-6 in the US gave people 600 micrograms per kilo for six days against a placebo, and it didn’t shorten the time to recovery. The UK’s PRINCIPLE trial was open-label, meaning no placebo, and reported that people felt better a bit sooner on average. But nothing moved on hospital admissions or deaths. 

So the overal picture is no clear benefit on the outcomes that matter most, like staying out of hospital. Some smaller early studies claimed otherwise, but several had design problems, and a few were withdrawn after serious concerns about the data.

Antiparasitic drug research isn’t finished, to be fair. Scientists are still looking at whether related compounds, or different approaches, might do something against particular viruses. That’s science doing its job. It isn’t a green light to try things at home.

Where these tablets genuinely belong

Parasitic infection treatment is what ivermectin was made for. Strongyloidiasis, river blindness (onchocerciasis), and doctors also use it for scabies. Its discoverers won a Nobel Prize in 2015, which is a decent sign it does its job.

Product listings describe Ivercare 12 mg as an ivermectin 12 mg tablet for parasitic infections of that sort.

Antiparasitic medicines are brilliant at what they were built for. People forget that. A drug being useless against a virus doesn’t make it a bad drug. It’s like complaining a hammer is rubbish at soup.

The “just in case” problem

What worries me most is how casual that screenshot was.

Ivercare 12 mg isn’t something to take for a virus, and a 12 mg tablet doesn’t suit everyone anyway. Doses are usually based on body weight, and pregnancy, other medicines, and some health conditions all matter. Too much ivermectin can cause nausea, vomiting, dizziness, confusion, and seizures. In the US, the FDA warned people off veterinary versions made for horses and cows, because they’re made for animals and can be dangerous for people.

There’s a quieter risk too. If you’re taking something that doesn’t treat a virus, you might skip something that does. Flu and COVID antivirals tend to work best when started early, within the first few days.

Using antiparasitic medicines this way, for something they don’t treat, means risk with no real upside.

So what does help with a virus?

Viral infection treatment, for most things, is dull. Rest, fluids, and paracetamol (acetaminophen in the US). The body does most of the work.

For some infections, there are specific antivirals. Flu, COVID, shingles, herpes, HIV, hepatitis C. Your GP, doctor, or pharmacist can say whether one fits, and whether you’re still within the window. Vaccines are the other half, and they work before you’re ill rather than after.

Evidence-based infection treatment sounds boring because it mostly is. Identify what you’ve got, pick a drug that hits that target, and follow the dose. No drama.

What I told my mate

That no, a worm tablet isn’t a cure for a virus, and the big trials didn’t back it up.

He asked, “So was it all rubbish?” Not quite. It was a reasonable question that got tested properly, and the answer turned out to be no. That’s how it’s meant to work, even if it’s less satisfying than a screenshot.

I still think about the dish, though. A promising lab result is a starting gun, not a finish line.

Antiparasitic medicines treat parasites. Viruses need drugs aimed at viruses. I know that sounds obvious now. It took me three evenings to feel it.

FAQs

1. Do antiparasitic medicines work against viruses?

Generally no. They target features of parasites that viruses don’t have.
Large, well-run trials have not found it to improve key outcomes like hospitalization or time to recovery.
Early lab results looked promising, but the doses used weren’t achievable in people.
No. Too much can cause serious side effects and it may delay treatment that actually works.
Speak to a GP, doctor or pharmacist, especially if you’re high-risk or symptoms are getting worse.

Leave a Reply

Your email address will not be published. Required fields are marked *